These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 3612896)

  • 1. Repeated oral doses of activated charcoal and the clearance of tobramycin, a non-absorbable drug.
    Watson WA; Jenkins TC; Velasquez N; Schentag JJ
    J Toxicol Clin Toxicol; 1987; 25(3):171-84. PubMed ID: 3612896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral activated charcoal and dapsone elimination.
    Neuvonen PJ; Elonen E; Mattila MJ
    Clin Pharmacol Ther; 1980 Jun; 27(6):823-7. PubMed ID: 7379451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of oral activated charcoal on tobramycin clearance.
    Davis RL; Koup JR; Roon RA; Opheim KE; Smith AN
    Antimicrob Agents Chemother; 1988 Feb; 32(2):274-5. PubMed ID: 3364947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the mechanisms of action of activated charcoal on theophylline pharmacokinetics.
    Mckinnon RS; Desmond PV; Harman PJ; Kamm M; Ghabrial H; Martin CJ; Mashford ML
    J Pharm Pharmacol; 1987 Jul; 39(7):522-5. PubMed ID: 2886620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of amitriptyline influenced by oral charcoal and urine pH.
    Kärkkäinen S; Neuvonen PJ
    Int J Clin Pharmacol Ther Toxicol; 1986 Jun; 24(6):326-32. PubMed ID: 3015809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of oral charcoal and urine pH on sotalol pharmacokinetics.
    Kärkkäinen S; Neuvonen PJ
    Int J Clin Pharmacol Ther Toxicol; 1984 Aug; 22(8):441-6. PubMed ID: 6092287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of oral charcoal and urine pH on dextropropoxyphene pharmacokinetics.
    Kärkkäinen S; Neuvonen PJ
    Int J Clin Pharmacol Ther Toxicol; 1985 Apr; 23(4):219-25. PubMed ID: 2987139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of orally administered activated charcoal on vancomycin clearance.
    Davis RL; Roon RA; Koup JR; Smith AL
    Antimicrob Agents Chemother; 1987 May; 31(5):720-2. PubMed ID: 3606073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acceleration of body clearance of diethylCarbamazine by oral activated charcoal.
    Orisakwe OE; Ilondu NA; Afonne OJ; Ofoefule SI; Orish CN
    Pharmacol Res; 2000 Aug; 42(2):167-70. PubMed ID: 10887047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of effect of oral activated charcoal on imipramine clearance.
    Goldberg MJ; Park GD; Spector R; Fischer LJ; Feldman RD
    Clin Pharmacol Ther; 1985 Sep; 38(3):350-3. PubMed ID: 4028632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acceleration of digoxin clearance by activated charcoal.
    Lalonde RL; Deshpande R; Hamilton PP; McLean WM; Greenway DC
    Clin Pharmacol Ther; 1985 Apr; 37(4):367-71. PubMed ID: 3978996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accelerated clearance of intravenously administered theophylline and phenobarbital by oral doses of activated charcoal in rats. A possibility of the intestinal dialysis.
    Arimori K; Nakano M
    J Pharmacobiodyn; 1986 May; 9(5):437-41. PubMed ID: 3761133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of charcoal, sodium bicarbonate, and ammonium chloride on chlorpropamide kinetics.
    Neuvonen PJ; Kärkkäinen S
    Clin Pharmacol Ther; 1983 Mar; 33(3):386-93. PubMed ID: 6297841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of activated charcoal on phenytoin pharmacokinetics.
    Rowden AM; Spoor JE; Bertino JS
    Ann Emerg Med; 1990 Oct; 19(10):1144-7. PubMed ID: 2221521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased serum theophylline clearance with orally administered activated charcoal.
    Mahutte CK; True RJ; Michiels TM; Berman JM; Light RW
    Am Rev Respir Dis; 1983 Nov; 128(5):820-2. PubMed ID: 6638669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expanded role of charcoal therapy in the poisoned and overdosed patient.
    Park GD; Spector R; Goldberg MJ; Johnson GF
    Arch Intern Med; 1986 May; 146(5):969-73. PubMed ID: 3516107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of orally administered activated charcoal on ciprofloxacin pharmacokinetics in healthy volunteers.
    Torre D; Sampietro C; Quadrelli C; Bianchi W; Maggiolo F
    Chemioterapia; 1988 Dec; 7(6):382-6. PubMed ID: 3219749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of single and repeated doses of activated charcoal on the pharmacokinetics of doxepin.
    Scheinin M; Virtanen R; Iisalo E
    Int J Clin Pharmacol Ther Toxicol; 1985 Jan; 23(1):38-42. PubMed ID: 3988390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure of oral activated charcoal to accelerate the elimination of amiodarone and chloroquine.
    Laine K; Kivistö KT; Neuvonen PJ
    Hum Exp Toxicol; 1992 Nov; 11(6):491-4. PubMed ID: 1361138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of activated charcoal on the pharmacokinetics of moxifloxacin following intravenous and oral administration of a 400 mg single dose to healthy males.
    Stass H; Kubitza D; Möller JG; Delesen H
    Br J Clin Pharmacol; 2005 May; 59(5):536-41. PubMed ID: 15842551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.